Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
German gas price bill signed into law, but consumers not impressed - 2'Fertiliser costs mean I'm better off not planting'
- 3Why is everyone talking about Paul Dano? George Clooney becomes the actor's latest defender in this 'time of cruelty.'
- 4Investigate These Retreats Well known With Seniors
- 5At least 55 injured in Russia after train crashes, overturns
- Extraordinary Snowboarding Objections All over the Planet
- Looking for under-the-radar adventures? Try Norway's Vesterålen
- The Delight of Camper Vans: Choosing the One That Meets Your Requirements
- Craig the beer-ambassador elephant dies aged 54
- Merz postpones Norway trip for Belgium talks on frozen Russian assets
- As tetanus vaccination rates decline, doctors worry about rising case numbers
- More than 3 million eye drops have been recalled from CVS, Walgreens and other national retailers. How to check if yours are safe
- Web designers for Independent ventures
- Key Little Things That Advantage Old People
